Good Friday Morning, Its October 21st, 2011, I’m Sara Bryant with CRWENewswire Stocks In Action. On its second quarter fiscal 2011, Flextronics International Limited - symbol FLEX - posted Net sales of $8.0 billion, an 8% increase year over year. Premiere Global Services Incorporated - symbol PGI - reported third quarter 2011 results, posting net revenues of $119.2 million, an 8.8% increase compared to the same period the prior year. and finally; Biogen Idec Incorporated - symbol BIIB - reported positive data from the Phase 3 DEFINE clinical trial of oral BG-12 (dimethyl fumarate) in people with relapsing-remitting multiple sclerosis. According to the company, The significant clinical and radiological responses in the trial are further evidence that BG-12 may become an oral therapy of choice for multiple sclerosis patients. Thanks for joining me and have a great weekend! For CRWE Newswire, Stocks In Action, I’m Sara Bryant